Clinical Trial Update: Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rapamycin for immunosuppression and B cell modulation after stem cell transplantation in acute lymphoblastic leukemia; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: University of Utah | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-07